Evolve BioSystems is dedicated to developing the next generation of products to establish, restore, and maintain a healthy newborn gut microbiome.
Building on a decade of expertise in the partnership between the infant gut microbiome and human breast milk, Evolve is solving newborn gut dysbiosis, or an imbalance of beneficial bacteria, through microbiome-based interventions in both human and animal health.
Evolve Bio’s Dr. Casaburi will be speaking on Thursday, May 10th, in a presentation titled "Targeted probiotic supplementation reduces antibiotic resistance gene carriage in breastfed infants" where he will be sharing Evolve's latest research on the impact of activated B. infantis ECV001 on the risk of antibiotic resistance in infants.
Funded By the Bill & Melinda Gates Foundation, Study Between Evolve BioSystems and the International Centre for Diarrhoeal Disease Research Will Determine Impact of Evivo Probiotic on Infants with Severe Acute Malnutrition
Evolve BioSystems is please to announce that Dr. David Kyle, Evolve Board Chairman and CSO, will be speaking at the upcoming Translational Microbiome Conference, April 18-20 in Boston.
Evolve BioSystems is proud to participate in the Animal Microbiome Congress USA, taking place March 21-22, 2018 in Kansas City! Dr. Steve Frese, Evolve's Associate Director of Research and Development, will be presenting our latest research on the newborn foal gut microbiome.
Dr. David Kyle, Evolve CSO, will be chairperson for the upcoming Microbiome Therapeutics Conference in Amsterdam, March 14-16.
Evolve BioSystems discovers dramatic shift indicating generational loss of good bacteria in baby’s gut microbiome.
Dr. David Kyle, Evolve BioSystems' CSO, will present exciting new data on the infant gut microbiome at the 4th Microbiome R&D and Business Collaboration Congress: Asia on March 5 – 6, 2018.
Evolve BioSystems, Inc. announced today a collaboration with King’s College London to study the effects of the probiotic Evivo™ in improving gut health in Caesarean-section delivered infants.
Dr. David Kyle, Evolve BioSystems' CSO, will present exciting new data on the infant gut microbiome at the 3rd Annual North American MIcrobiome Congress in San Diego, CA on February 6th.
Evolve BioSystems is proud to participate at the 55th Annual Ocala Equine Conference, in Ocala, Fl Jan 19th-21st. Come visit us at GlycoGuard Booth #3!